Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nrc Health (NRC) Dividends payables (2016 - 2026)

Nrc Health's Dividends payables history spans 12 years, with the latest figure at $3.6 million for Q4 2025.

  • On a quarterly basis, Dividends payables rose 30.87% to $3.6 million in Q4 2025 year-over-year; TTM through Dec 2025 was $3.6 million, a 30.87% increase, with the full-year FY2025 number at $3.6 million, up 30.87% from a year prior.
  • Dividends payables hit $3.6 million in Q4 2025 for Nrc Health, up from $2.7 million in the prior quarter.
  • Over the last five years, Dividends payables for NRC hit a ceiling of $6.0 million in Q1 2022 and a floor of $2.7 million in Q3 2025.
  • Historically, Dividends payables has averaged $3.4 million across 5 years, with a median of $2.9 million in 2023.
  • Biggest five-year swings in Dividends payables: skyrocketed 94.69% in 2022 and later crashed 51.17% in 2023.
  • Tracing NRC's Dividends payables over 5 years: stood at $3.0 million in 2021, then decreased by 2.89% to $3.0 million in 2022, then dropped by 1.69% to $2.9 million in 2023, then decreased by 4.68% to $2.8 million in 2024, then soared by 30.87% to $3.6 million in 2025.
  • Business Quant data shows Dividends payables for NRC at $3.6 million in Q4 2025, $2.7 million in Q3 2025, and $2.8 million in Q2 2025.